Crossmark

First-in-human exploratory trial assessing safety, feasibility, and efficacy of artificial protein (silk-elastin) in promoting healing in patients with meniscus injuries

Crossref DOI link: https://doi.org/10.1038/s41598-025-88616-x

Published Online: 2025-02-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ishikawa, Masakazu

Tsuji, Shunya

Kamei, Goki

Nakata, Kyohei

Nekomoto, Akinori

Hashiguchi, Naofumi

Nakasa, Tomoyuki

Nakamae, Atsuo

Kamei, Naosuke

Inoue, Keiichiro

Kawabata, Shingo

Ueda, Keiko

Adachi, Nobuo
Funding

Funding for this research was provided by:

Japan Agency for Medical Research and Development (20im0210222, 20im0210222, 20im0210222, 20im0210222, 20im0210222)
License Information

Text and Data Mining valid from 2025-02-07

Version of Record valid from 2025-02-07
More Information

Article History

Received: 11 October 2024

Accepted: 29 January 2025

First Online: 7 February 2025

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below